Medivation Announces Participation at Upcoming Investor Conferences

SAN FRANCISCO, CA--(Marketwired - April 27, 2016) -  Medivation, Inc. (NASDAQ: MDVN) today announced that David Hung, M.D., founder, president, and chief executive officer, and Jennifer Jarrett, chief financial officer, will participate in a fireside chat at the following healthcare conferences:

• Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 11, 2016 at 8:00am PT at the Encore at Wynn in Las Vegas, NV.
• UBS Global Healthcare Conference on Monday, May 23, 2016 at 10:00am ET at the Grand Hyatt in New York, NY.

Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at http://www.medivation.com.

Contact:
Anne Bowdidge 
Sr. Director, Investor Relations 
[phone]